Constellation Vision System
510(k) K101285
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK101285 | Date12 Nov 2010 | StatusActive |
Recalls
-
- Ongoing Z-0099-2024
Ophthalmic microsurgical vision systems have a new Printed Circuit Board (PCB) design that could lead to higher voltage to a PCB component, that could cause component failure and loss of pressure control for the use of cutters, scissors, and forceps, which could lead to an increased risk of microbial infection, tissue damage and progressive visual impairment.
-
- Terminated Z-1794-2020
There was a potential that a 25-gauge infusion cannula may be included within the procedure pak instead of a 20-gauge infusion cannula.
-
- Terminated Z-0778-2018
- Terminated Z-0779-2018
Alcon is conducting this Voluntary Medical Device Recall for a specific lot (2060953H) of its 25+ TOTALPLUS Vitrectomy Pak due a potential that a 23GA ULTRAVIT probe may be included within the 25+ TOTALPLUS Vitrectomy Pak, instead of a 25+ ULTRAVIT probe.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HQC
- Device Class
- Class II
- Regulation
- 21 CFR Part 886.4670
- Advisory Committee
- Ophthalmic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Constellation Vision System is a vitrectomy platform designed for intraocular surgical procedures. It employs phacofragmentation technology to assist in cataract and vitreoretinal surgeries, facilitating precise tissue removal and manipulation within the eye.
This device is intended for use in ophthalmic settings and is supplied as a reusable medical instrument. It is classified as a Class II device under FDA regulations and has received FDA 510K clearance as substantially equivalent to predicate devices. The system includes multiple model variants, as indicated by the associated registration numbers, and is regulated under FDA regulation number 886.4670.